CIR Review Summary May 6, 2026 3 min read

Triethanolamine and Triethanolamine-Containing Ingredients: CIR Safety Assessment Summary

CIR safety assessment summary for Triethanolamine and Triethanolamine-Containing Ingredients: ingredients reviewed, panel verdict, use concentration conte.

Triethanolamine and Triethanolamine-Containing Ingredients appears in a CIR safety assessment covering Triethanolamine and Triethanolamine-Containing Ingredients. The panel verdict for the report is safe with restrictions. Reference Previously reviewed ingredients TEA Safe for use in cosmetic formulations designed for discontinuous, brief use followed by thorough rinsing from the surface of the skin; in products intended for prolonged contact with the skin, the concentration of diethanolamine should not exceed 5%; should not be used with products containing N-nitrosating agents.

FieldCIR value
Primary ingredientTriethanolamine and Triethanolamine-Containing Ingredients
CIR verdictsafe with restrictions
Report typeSafety Assessment
DateIn 1983
CAS numbers102-71-6, 637-39-8, 7376-31-0, 2224-49-9, 41669-40-3, 49719-60-0, 4568-28-9, 88120-12-1, 2717-15-9
Use concentration context5%; 10%; 30%; 10.5%
Conditions or carve-outs

Ingredients Reviewed

The review scope matters because CIR conclusions often apply to an ingredient family rather than a single INCI name. In this report, the ingredient list includes Triethanolamine and Triethanolamine-Containing Ingredients.

Safety Conclusion

The conclusion for Triethanolamine and Triethanolamine-Containing Ingredients should be read as a CIR panel conclusion, not a regulatory limit. CIR assessments summarize expert-panel safety determinations for cosmetic use, while legal status still depends on the jurisdiction and product category.

For use levels, the report gives this concentration context: 5%; 10%; 30%; 10.5%. That language is the safe-use context shown for this page.

Conditions

Reference Previously reviewed ingredients TEA Safe for use in cosmetic formulations designed for discontinuous, brief use followed by thorough rinsing from the surface of the skin; in products intended for prolonged contact with the skin, the concentration of diethanolamine should not exceed 5%; should not be used with products containing N-nitrosating agents.

Formulation Reading

For formula review, begin with the exact INCI identity and the ingredient group covered by the CIR assessment. If the material is Triethanolamine and Triethanolamine-Containing Ingredients, the relevant comparison is whether the intended use aligns with the practices, concentration ranges, and conditions described in the CIR source.

The ingredient hub at Triethanolamine and Triethanolamine-Containing Ingredients should carry the substance-level profile. This page is the report-level summary, keeping the conclusion, ingredient scope, and use-context language attached to the CIR source rather than treating the conclusion as a universal permission.

Why This Page Exists

CIR reviews are long documents, and the practical answer is usually buried in the conclusion and the table of current practices. This summary keeps those CIR facts in one indexable page for Triethanolamine and Triethanolamine-Containing Ingredients, with source details retained at the bottom for audit.


Source

  • CIR report: Safety Assessment of Triethanolamine and Triethanolamine-Containing Ingredients as Used in Cosmetics Monice M. Fiume1, Bart Heldreth2, Wilma F. Bergfeld3, Donald V. Belsito3, Ronald A. Hill1, Curtis D. Klaassen3, Daniel Liebler3,
  • CIR source file: PRS594.pdf
  • Extraction JSON: CIR Safety Assessment Database
  • Conclusion page in CIR extraction: 2